BPH Energy

BPH Energy Limited is a diversified company based in North Perth, Australia, engaged in biomedical research and oil and gas exploration. The company is developing advanced medical technologies, including the Brain Anaesthesia Response (BAR) Monitor, which assesses brain electrical activity during surgery, and the HLS5 Tumour Suppress Gene, aimed at enhancing cancer detection. BPH Energy holds a 100% interest in RL1 oil and gas assets in the onshore Bonaparte basin and an 85% interest in a petroleum exploration permit in the offshore Sydney basin. Additionally, the company is involved in the medicinal cannabis sector. It focuses on commercializing a range of biomedical technologies developed through collaborations with Australian universities and medical institutions.